10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, has scheduled its Q2 2025 earnings release for August 7, 2025, after market close. The company will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET to discuss financial results and business developments.
The earnings release will be available on the company's website before the call, and investors can access the live webcast through the investor relations section. A replay will be available for at least 45 days following the event.
10x Genomics (Nasdaq: TXG), leader nella biologia cellulare singola e spaziale, ha programmato il rilascio dei risultati del secondo trimestre 2025 per il 7 agosto 2025, dopo la chiusura del mercato. L'azienda terr脿 una conference call e una webcast alle 13:30 PT / 16:30 ET per discutere i risultati finanziari e gli sviluppi aziendali.
Il comunicato sui risultati sar脿 disponibile sul sito web della societ脿 prima della chiamata, e gli investitori potranno accedere alla diretta streaming tramite la sezione relazioni con gli investitori. Una registrazione sar脿 disponibile per almeno 45 giorni dopo l'evento.
10x Genomics (Nasdaq: TXG), l铆der en biolog铆a celular 煤nica y espacial, ha programado su publicaci贸n de resultados del segundo trimestre de 2025 para el 7 de agosto de 2025, despu茅s del cierre del mercado. La compa帽铆a realizar谩 una llamada conferencia y una transmisi贸n en vivo a las 1:30 PM PT / 4:30 PM ET para discutir los resultados financieros y desarrollos comerciales.
El comunicado de resultados estar谩 disponible en el sitio web de la empresa antes de la llamada, y los inversores podr谩n acceder a la transmisi贸n en vivo a trav茅s de la secci贸n de relaciones con inversores. Una grabaci贸n estar谩 disponible por al menos 45 d铆as despu茅s del evento.
10x Genomics (雮橃姢雼�: TXG)電� 雼澕 靹疙彫 氚� 瓿店皠 靸濍頃� 攵勳暭鞚� 靹犽憪欤检瀽搿滌劀 2025雲� 2攵勱赴 鞁れ爜 氚滍憸毳� 2025雲� 8鞗� 7鞚� 鞁滌灔 毵堦皭 頉�鞐� 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 鞛 瓴瓣臣 氚� 靷梾 臧滊皽鞐� 雽�頃� 雲检潣頃橁赴 鞙勴暣 鞓ろ泟 1:30 PT / 鞓ろ泟 4:30 ET鞐� 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
鞁れ爜 氚滍憸電� 旖� 鞝勳棎 須岇偓 鞗轨偓鞚错姼鞐愳劀 鞝滉车霅橂┌, 韴瀽鞛愲摛鞚� 韴瀽鞛� 甏�瓿� 靹轨厴鞚� 韱淀暣 霛检澊敫� 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨姷雼堧嫟. 鞚措菠韸� 頉� 斓滌唽 45鞚缄皠 雼れ嫓氤搓赴 靹滊箘鞀り皜 鞝滉车霅╇媹雼�.
10x Genomics (Nasdaq : TXG), un leader en biologie cellulaire unique et spatiale, a programm茅 la publication de ses r茅sultats du deuxi猫me trimestre 2025 pour le 7 ao没t 2025, apr猫s la fermeture du march茅. La soci茅t茅 organisera une conf茅rence t茅l茅phonique et un webcast 脿 13h30 PT / 16h30 ET pour discuter des r茅sultats financiers et des d茅veloppements commerciaux.
La publication des r茅sultats sera disponible sur le site web de la soci茅t茅 avant l'appel, et les investisseurs pourront acc茅der au webcast en direct via la section des relations investisseurs. Une rediffusion sera disponible pendant au moins 45 jours apr猫s l'茅v茅nement.
10x Genomics (Nasdaq: TXG), ein f眉hrendes Unternehmen im Bereich der Einzelzell- und Raumbiologie, hat die Ver枚ffentlichung der Ergebnisse f眉r das zweite Quartal 2025 f眉r den 7. August 2025 nach B枚rsenschluss geplant. Das Unternehmen wird eine Telefonkonferenz und einen Webcast um 13:30 Uhr PT / 16:30 Uhr ET abhalten, um die Finanzergebnisse und Gesch盲ftsentwicklungen zu besprechen.
Die Ergebnisver枚ffentlichung wird vor der Telefonkonferenz auf der Unternehmenswebsite verf眉gbar sein, und Investoren k枚nnen 眉ber den Bereich Investor Relations auf den Live-Webcast zugreifen. Eine Aufzeichnung wird mindestens 45 Tage nach der Veranstaltung verf眉gbar sein.
- None.
- None.
Live audio of the webcast will be available on the "Investors" section of the company website at: . The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 听辞谤 connect with us on LinkedIn, , Facebook, Bluesky听辞谤 YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
滨苍惫别蝉迟辞谤蝉:听[email protected]
惭别诲颈补:听[email protected]
View original content to download multimedia:
SOURCE 10x Genomics, Inc.
FAQ
When will 10x Genomics (TXG) report Q2 2025 earnings?
What time is the 10x Genomics Q2 2025 earnings call?
How can I access the 10x Genomics Q2 2025 earnings call?
How long will the 10x Genomics Q2 2025 earnings call replay be available?
